International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
File(s) ncomms9019.pdf (300.9 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined <5 × 10-8) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist.
Date Issued
2015-09-22
Date Acceptance
2015-07-03
Citation
Nature Communications, 2015, 6
ISSN
2041-1723
Publisher
Nature Publishing Group: Nature Communications
Journal / Book Title
Nature Communications
Volume
6
Copyright Statement
© 2015 The Authors, published by Macmillan Publishers Limited. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Subjects
MD Multidisciplinary
Publication Status
Published
Article Number
8019
